Skip to content

Clinical trials

Phase 1/2 trials in Indonesia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 1/2 Country / region: Indonesia Clear all

47 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20121
20131
20162
20182
20195
20203
20214
202213
20232
20247
20253
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Unknown status10
Active, not recruiting6
Recruiting5
Enrolling by invitation2
Not yet recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
PT. Prodia Stem Cell Indonesia11
Indonesia University10
Universitas Sebelas Maret6
Universitas Padjadjaran3
Dr. Soetomo General Hospital2
Gadjah Mada University2
Adimmune Corporation1
CanSino Biologics Inc.1
Dexa Medica Group1
Hayandra Peduli Foundation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
COVID-194
Osteoarthritis, Knee4
Acne Vulgaris3
Diabetes Mellitus, Type 23
Arthritis, Rheumatoid2
Diabetic Nephropathies2
Inflammation2
Osteoarthritis2
Respiratory Distress Syndrome2
Urinary Tract Infections2

Trials

Showing 76 to 47 of 47. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.